Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Survival Benefit of Anti-HIV Agents Not Compromised in Drug Abusers
Link ID 7400
Title Survival Benefit of Anti-HIV Agents Not Compromised in Drug Abusers
Url http://www.medscape.com/viewarticle/578572?src=rss
Description New research indicates that HIV-infected injection drug users glean as much benefit from highly active antiretroviral therapy (HAART) as do patients without this history. Reuters Health Information
Category Articles > HIV/AIDS
Keywords
Date Aug 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > HIV/AIDS
1. Novel Antiviral Agent Shows Safety, Activity Against HIV-1
  A human IgG4 monoclonal antibody that binds to the CC chemokine receptor 5 (CCR5) is well-tolerated and shows "meaningful antiviral activity" against CCR5-tropic HIV-1, according to the results of a phase II trial. Reuters Health Information
Category:   Articles > HIV/AIDS


2. Akt Inhibitors Target HIV-Infected Macrophages
  Akt inhibitors, including miltefosine, promote cell death of HIV-infected macrophages without harming uninfected cells, according to a report in the January 31st issue of Retrovirology. Reuters Health Information
Category:   Articles > HIV/AIDS


3. South Africa AIDS Activist Urges New TB Plan
  African nations are failing to control tuberculosis and could be overwhelmed by drug resistant strains of the infectious lung disease, with dire implications for the war on AIDS, a leading AIDS activist said on Monday. Reuters Health Information
Category:   Articles > HIV/AIDS


4. Treatment Strategies in HIV Infection: Revised Guidelines and New Data -- An Expert Interview With D
  Dr. Sharon Walmsley shares her expertise, as a member of the IAS-USA panel on treatment recommendations, on the newly released revisions for 2008. Medscape HIV/AIDS
Category:   Articles > HIV/AIDS


5. Pegylated Liposomal Doxorubicin Prevents Relapse of HIV-Related Kaposi Sarcoma
  Among HIV-infected patients treated with pegylated liposomal doxorubicin for Kaposi sarcoma (KS), relapse rates are low, according to a report in the August 1st issue of Clinical Infectious Diseases. Reuters Health Information
Category:   Articles > HIV/AIDS




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS